ArticleMolecular cancer therapeutics2023

Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model.

Rupali Sharma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.